GTx ( GTXI) is a biopharmaceutical company dedicated to the discovery, development and commercialization of small molecules that targets hormone pathways to treat cancer, osteoporosis and bone loss, muscle loss and other serious medical conditions. This stock is trading up 15.8% at $3.59 in recent trading. Today's Range: $3.30-$3.76 52-Week Range: $2.34-$6.86 Volume: 2.1 million Three-Month Average Volume: 493,015 From a technical perspective, GTXI is ripping higher today as the stock moves back above its 50-day moving average of $3.46 with monster volume. This move also has GTXI flirting with its 200-day moving average of $3.66, since it hit an intraday high of $3.76. Traders should now look for long-biased trades if GTXI can manage to sustain a high-volume move or close back above its 200-day moving average. Look for volume on that move that's near or above 493,015 shares. If we get that close today, look for GTXI to make a run at its March high of $4.07. Keep in mind that GTXI has a huge gap from February that started at $6 that could get filled if the stock can maintain an uptrend above $4.07.